Bruno Chiappini

Cox/Maze III operation versus radiofrequency ablation for the surgical treatment of atrial fibrillation: a comparative study

BACKGROUND The purpose of this study was to evaluate the efficacy of radiofrequency (RF) ablation in the treatment of atrial fibrillation, by comparatively analyzing the outcomes of the patients who underwent RF ablation with those of patients who underwent Cox/Maze III surgery. METHODS Between April 1995 and June 2002, 70 patients underwent surgery for atrial fibrillation and open-heart surgery at the Department of Cardiovascular Surgery of the University of Bologna: 30 patients underwent the surgical Cox/Maze III procedure (group 1), and 40 patients underwent the RF ablation according to the Maze III configuration at least on the left atrium (group 2). There were 14 males and 56 females, with a mean age of 61.5 +/- 12.5 years (range 22 to 80 years old). RESULTS Groups 1 and 2 did not differ in terms of baseline characteristics. The perioperative mortality rate was not significantly different between the two groups (6.6% in group 1 vs 7.5% in group 2). The overall cumulative rates of sinus rhythm were 68.9% in group 1 and 88.5% in group 2 (not statistically significant). Biatrial contraction was assessed by transthoracic echocardiography in 70.4% of the patients in group 1 and 76.5% of the patients in group 2 (p = 0.65). CONCLUSIONS The RF ablation procedure offers as good results as the Cox/Maze III operation, allowing recovery of the sinus rhythm and atrial function in the great majority of patients with atrial fibrillation who underwent open heart surgery; it is a safe and effective means of curing atrial fibrillation with negligible technical and time requirements.

Surgery for atrial fibrillation using radiofrequency catheter ablation.

OBJECTIVE We present the results obtained in 40 patients with chronic atrial fibrillation using direct intraoperative radiofrequency to perform atrial fibrillation surgery. METHODS Between April 2001 and June 2002, 40 patients underwent surgery for atrial fibrillation using radiofrequency ablation and cardiac surgery at the Department of Cardiovascular Surgery of the University of Bologna [corrected]. There were 8 men and 32 women with a mean age of 62 +/- 11.6 years (range: 20 to 80 years). RESULTS Concomitant surgical procedures were: mitral valve replacement (n = 13), mitral valve replacement plus tricuspid valvuloplasty (n = 11), combined mitral and aortic valve replacement (n = 8), and combined mitral and aortic valve replacement plus tricuspid valvuloplasty (n = 5). Moreover, 1 patient underwent tricuspid valvuloplasty plus atrial septal defect repair, another required aortic valve replacement plus coronary artery bypass graft, and a third underwent aortic valve replacement. After the mean follow-up time of 16.5 +/- 2.5 months survival was 92.8% and the overall cumulative rate of sinus rhythm was 88.5%. CONCLUSIONS We conclude that the radiofrequency ablation procedure is a safe and effective means of curing atrial fibrillation with negligible technical and time requirements, allowing recovery of the sinus rhythm and atrial function in the great majority of patients with atrial fibrillation who underwent cardiac surgery (88.5% of our study population).

Simultaneous Carotid and Coronary Arteries Disease: Staged or Combined Surgical Approach?

Abstract  Background: Patients suffering from a concomitant coronary and carotid artery occlusive disease represent a high‐risk population whose management remains controversial. Methods: Between April 1979 and June 2002, 202 patients (163 men and 39 women, mean age 65 ± 7 years) were admitted at the Department of Cardiovascular Surgery of the University of Bologna for coronary artery bypass graft and carotid endarterectomy (CEA). In Group 1 (140 patients) coronary artery bypass graft and carotid endarterectomy were performed simultaneously while in Group 2 (62 patients) they were performed as two‐staged procedures. Results: The rate of postoperative stroke was 6.4% in Group 1 (9/140) and 4.8% in Group 2 (3/62). Significant univariate predictors of myocardial infarction were smoking history and previous myocardial infarction; for stroke they were older, greater than 70 years, and a smoking history; for death the significant predictors were the operative approach, the low ejection fraction, smoking history, renal failure, and peripheral vascular occlusive disease. The hospital mortality was 6.4% in Group 1 versus 12.9% in Group 2. Conclusions: Despite the highly selected populations, the contemporary surgical results indicate that the management of these patients needs careful pre‐, intra‐, and postoperative assessment and timing aimed at reducing the ischemic injuries, both cerebral and cardiac, therefore we believe that the surgical technique should be individualized for each patient.

Radiofrequency ablation for atrial fibrillation: different approaches.

The existing literature regarding radiofrequency ablation for the surgical treatment of atrial fibrillation was reviewed, analyzing the early and late results. A MEDLINE search supplemented with a manual bibliographic review was performed for all peer-reviewed English language articles regarding the use of radiofrequency ablation for the treatment of atrial fibrillation. Six studies were identified, with a total of 451 patients. None of the studies was completely randomized. All patients underwent radiofrequency ablation as an adjunct to a variety of cardiac surgical procedures. The hospital mortality rate was 2.7%. The overall survival rate was 97.1%, and freedom from atrial fibrillation was 76.3% ± 5.1% after a mean follow-up period of 13.8 ± 1.9 months. It was concluded that radiofrequency ablation should be considered a safe and effective means to cure atrial fibrillation in patients undergoing open heart surgery.

Clinical Outcome of Aortic Valve Replacement in the Elderly

Since elderly patients are being referred for surgery in increasing numbers, we reviewed the clinical outcome of 459 consecutive patients aged 70 to 89 years, who had aortic valve replacement between 1993 and 2000. We subdivided the study population into three groups: in Group 1 we included patients aged 70-74 years old; in Group 2 patients aged 75-79 years old; and in Group 3 patients aged 80 years old or older. An isolated AVR was performed in 289 patients (63%), concomitant coronary artery bypass graft (CABG) in 168 patients (36.6%), an isolated ventricular septal defect (VSD) closure in one patient (0.2%) and an isolated atrial septal defect (ASD) closure in one patient (0.2%). The overall perioperative mortality rate was 7% (32 patients), without significant differences among the three groups (P=0.88). Our study confirms the good outcome of aortic valve replacement in elderly patients even in octagenarians and only concomitant CABG procedures increase the operative risk, reducing long-term survival (P<0.05).

The surgical treatment of atrial fibrillation with microwave ablation: preliminary experience and results

Atrial fibrillation (AF) is associated with a significant mortality and morbidity. Microwave (MW) ablation is a new technology for surgical treatment of this arrhythmia. We present our preliminary experience with MW ablation in patients with AF who underwent a concomitant open-heart surgery. From October 2001 to March 2002, a total of 10 patients underwent MW ablation of AF and an open-heart surgery at the Department of Cardiovascular Surgery of the University of Bologna. All patients experienced chronic AF and the mean duration of rhythm disturbance was 82.8 months, ranging from 24 to 360 months. There was no complication related to the surgical procedure. The overall survival rate, after discharge, was 100% and sinus rhythm recovery rate was 77.8% after a mean follow-up time of 12.4 months (10-15 months). Our preliminary results show that MW ablation may be a very effective way of converting patients with atrial fibrillation into sinus rhythm.

Absolute and relative risk prediction in patients candidate to isolated aortic valve replacement: should we change our mind?

OBJECTIVE The European System for Cardiac Operative Risk Evaluation (EuroSCORE) calculator performance in 30-day outcome prediction after isolated aortic valve replacement (AVR) was evaluated to assess its absolute reliability and usefulness as selection criteria to percutaneous aortic valve implantation (PAVI). METHODS We carried out a retrospective statistical analysis on 379 patients (group 0) consecutively submitted to isolated AVR in the past 10 years of surgical activity. We discriminated two periods of 5 years each, so we considered two subgroups of patients: group 1 (200 patients operated during 1999-2003); group 2 (179 patients operated during 2004-2008). We used receiver operating characteristics (ROC) curves for discriminatory power analysis. Model calibration was evaluated with the Hosmer-Lemeshow goodness-of-fit test and Pseudo R(2) analysis. RESULTS The overall expected mortality rate at the logistic calculator was 9.37% compared with an observed 10-year mortality of 5.2% (p=0.006). Absolute risk prediction in group 1 fitted the observed outcome (p=0.24) while expected mortality in group 2 was significantly higher than observed (p=0.005). Applying threshold values used as PAVI selection criteria (logistic EuroSCORE >20 or >15), against 29% and 24.3% expected mortality rate, respectively, we registered a significant difference in the observed values (11.4%, p=0.022; 8.6%, p=0.005, respectively). The Hosmer-Lemeshow test demonstrated a lack of model fit in the overall group (p=0.019). ROC analysis revealed a sufficient discriminatory power for either total population (logistic area under curve (AUROC) 0.706; 95% confidence interval (CI): 0.604-0.809; p=0.002) and group 1 (logistic AUROC 0.752; 95% CI: 0.643-0.860; p=0.002). Group 2 showed a lack of risk stratification (logistic AUROC 0.613; 95% CI: 0.401-0.824; p=0.348). CONCLUSIONS EuroSCORE appears to be an invalid model in absolute and relative risk prediction for isolated AVR. On this basis, its use in selecting candidates to PAVI should be carefully weighted. Correct stratification and sufficient calibration of absolute risk estimate of high-risk patients are, therefore, mandatory in the aim of assigning those patients who show risk factors really responsible for the worst surgical outcome to new techniques. The goal should be reached by exploring the weight of each independent predictor of death in each single institution involved in PAVI procedures, evaluating local surgical results in terms of absolute risk and analysing those variables significantly affecting relative risk.

Embolization of an Amplatzer Atrial Septal Closure Device to the Pulmonary Artery

Abstract  A 44‐year‐old woman with a history of transient ischemic attack underwent closure of atrial septal defect with a 26 mm Amplatzer device. The device was released without residual shunt or impingement on intracardiac structures. Within seconds, the transesophageal echocardiography showed the initial dislodgement of the device from the atrial septum and its consequent slipping back into the right atrium close to the tricuspid valve. Soon after the device disappeared from the right atrium and it could be founded into the right ventricle under the tricuspid valve. The patient was transferred in the operating room for an emergency operation. The device could not be found in the right ventricle because its downstream migration. The Amplatzer septal occluder was identified by palpation into the pulmonary artery trunk: it was retrieved from the right ventricle through the pulmonary valve and the atrial septal defect was closed by running suture.

Surgical management of double outlet right ventricle with intact ventricular septum

A very rare case of double outlet right ventricle with intact ventricular septum and unrestricted pulmonary flow was successfully palliated with pulmonary banding and delayed bidirectional cavopulmonary anastomosis and mitral avulsion. This is the only case of pulmonary banding with mitral avulsion reported in the literature for this type of heart defect

Cardiac hemangioma of the left atrial appendag: a case report and discussion.

Abstract  Cardiac hemangioma is an extremely rare, benign vascular tumor of the heart. In contrast to myxoma, hemangioma rarely involves left atrial tissue in adults and little information about the tumor is available. We encountered a 65‐year‐old woman with a left atrial hemangioma arising in the appendage and growing like an extracardiac mass. The tumor was removed from the left atrium with all the left appendage under cardiopulmonary bypass. Histopathological examination revealed that it was a cavernous‐type hemangioma. Among the five described cases, this case was the only one in which the tumor arose from the appendage and grew into the pericardial cavity with resultant paroxystic atrial fibrillation.